GE Healthcare extends manufacturing deal
Albany Molecular Research (AMRI) has renewed its manufacturing agreement with GE Healthcare, set to expire in 2007, until December 2010.
Albany Molecular Research (AMRI) has renewed its manufacturing agreement with GE Healthcare, set to expire in 2007, until December 2010.
Under the terms of the agreement AMRI will supply and produce increased quantities of an unnamed raw material for use in GE's diagnostic imaging agents. The work will be conducted at Organichem Corporation, AMRI's large scale manufacturing subsidiary in Rensselaer, New York, US. Financial terms were not disclosed.
'The renewal of this relationship is a significant event for us and should help provide a stable revenue base at our large scale manufacturing subsidiary while we continue to bring in additional development and clinical trial materials manufacturing agreements,' said AMRI chairman, ceo and president Thomas E. D'Ambra, Ph.D.